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The pathogenesis of Shigella flexneri requires a functional
type III secretion apparatus to serve as a conduit for injecting
host-altering effector proteins into the membrane and cyto-
plasm of the targeted cell. The type III secretion apparatus is
composed of a basal body and an exposed needle that is an
extended polymer of MxiH with a 2.0-nm inner channel. Inva-
sion plasmid antigen D (IpaD) resides at the tip of the needle to
control type III secretion. The atomic structures of MxiH and
IpaD have been solved. MxiH (8.3 kDa) is a helix-turn-helix,
whereas IpaD (36.6 kDa) has a dumbbell shapewith twoglobular
domains flanking a central coiled-coil that stabilizes theprotein.
These structures alone, however, have not been sufficient to
produce a workable in silico model by which IpaD docks at the
needle tip. Thus, the work presented here provides an initial
step in understanding this important protein-protein interac-
tion. We have identified key MxiH residues located in its PSNP
loop and the contiguous surface that uniquely contribute to the
formation of the IpaD-needle interface as determined by NMR
chemical shift mapping. Mutation of Asn-43, Leu-47, and
Tyr-50 residues severely affects the stable maintenance of IpaD
at the Shigella surface and thus compromises the invasive phe-
notype of S. flexneri. Other residues could be mutated to give
rise to intermediate phenotypes, suggesting they have a role in
tip complex stabilization while not being essential for tip com-
plex formation. Initial in vitro fluorescence polarization studies
confirmed that specific amino acid changes adversely affect the
MxiH-IpaD interaction. Meanwhile, none of the mutations
appeared to have a negative effect on the MxiH-MxiH interac-
tions required for efficient needle assembly.
Shigella flexneri is a Gram-negative bacterium and the caus-
ative agent of shigellosis, a potentially life-threatening form of
bacillary dysentery. Although shigellosis is often considered a
disease restricted to the developingworld, it is also a problem in
industrialized nations as an infectious agent in daycare centers,
nursing homes, and situations where public health infrastruc-
ture becomes compromised (1). The problems posed by shigel-
losis are compounded by increasing numbers of antibiotic-re-
sistant isolates and the need to send aid personnel to endemic
areas (2).
Once ingested, Shigella passes through the stomach to the
colonic mucosa where it crosses M cells into gut-associated
lymphoid tissues (3). The bacterium then enters macrophages
and induces them to undergo apoptosis (4), which leads to
release of the pathogen at the basolateral side of the colonic
epithelium. Shigella then promotes its own uptake into epithe-
lial cells by inducing cytoskeletal rearrangements in these cells
(5, 6). The pathogenesis of S. flexneri requires a functional type
III secretion system (6). Type III secretion systems are a shared
virulence determinant for many Gram-negative animal and
plant pathogens, and they are used to deliver protein effectors
to targeted cells to subvert normal cellular functions (7, 8). The
type III secretion apparatus (TTSA)2 visually resembles a
molecular needle and syringe (9, 10). It is composed of a basal
body that spans both bacterial membranes and an exposed nee-
dle that is a polymer of MxiH. The needle is 50 nm in length,
has an outer diameter of 7.0 nm, and possesses an inner channel
that is 2.0–3.0 nm in diameter (10, 11). We recently demon-
strated that invasion plasmid antigen D (IpaD) localizes to the
tip of the TTSA needle (12), where it controls secretion of the
translocator proteins IpaB and IpaC and directs their insertion
into host cell membranes (13). From its position at the TTSA
needle tip, IpaD is responsible for recruiting and stably main-
taining IpaB to this site in the presence of bile salts (14). This is
an essential step for Shigella invasiveness, and the interactions
between IpaD and MxiH that are responsible for tip complex
stabilization are thus critical for Shigella pathogenesis (12, 14).
The high resolution structures of MxiH and IpaD were
recently reported (15, 16). MxiH monomers possess a helix-
turn-helix head group with an elongated C-terminal helix (15).
The head group is stabilized by hydrophobic contacts of resi-
dues at the interface between the two helices that flank a central
PSNP loop (15). Likewise, the TTSA needle appears to pack by
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polar contacts between the individual MxiH monomers with
the PSNP loop facing outward and upward relative to the cen-
tral channel (15). In contrast toMxiH, IpaDhas amore complex
structure that gives it a dumbbell shape (16). IpaD has a central
coiled-coil that defines the handle of the dumbbell and is
flanked at each end by distinctN- andC-terminal domains (16).
This shape defines the tip proteins as a unique class (17) and
appears to be important for IpaD localization at the tip of the
needle (12). Based on in silicomodeling of the Yersinia tip com-
plex protein LcrV on the Shigella MxiH needle tip, the LcrV
N-terminal globular domain and the C-terminal end of the
coiled-coil are both required in docking LcrV on the needle
(15). Although the IpaD structure shows that the N-terminal
domain canmimic aMxiHmolecule andpossibly serve to chap-
erone the C-terminal coil to prevent the binding of MxiH and
IpaD in the cytoplasm, how IpaD docks to MxiH could not be
resolved even after the structure of the two proteins became
available (16). Nevertheless, interactions in addition to those
that dictate needle assembly would be expected to be involved
in maintaining IpaD at the needle tip. We therefore chose to
examine the structural basis for the interaction between MxiH
and IpaD. The data presented here show that specific residues
within the MxiH head group are located at the MxiH-IpaD
interface. These residues are needed for stable maintenance of
IpaD at the TTSA needle tip but are distinct from those needed
for needle assembly.
EXPERIMENTAL PROCEDURES
Materials—Antibodies to MxiH and IpaD were a kind gift
from E. V. Oaks (Walter Reed Army Institute for Research, Sil-
ver Springs, MD). The S. flexneri mxiH null strain SH116 was
fromA. Allaoui (Brussels, Belgium) and grown at 37 °C in tryp-
ticase soy agar containing 0.025%Congo red to ensure the pres-
ence of the virulence plasmid. Sheep red blood cells were from
Colorado Serum Company (Denver, CO). Fluorescent probes
and Alexa Fluor-labeled secondary antibodies were from
Molecular Probes (Eugene, OR). Escherichia coli Tuner(DE3),
pET15b, pET22b, and ligation reagents were from Novagen
(Madison, WI). Restriction enzymes were from New England
Biolabs (Tozer, MA). Oligonucleotide primers were from IDT
(Coralville, IA). 15N-Ammonium chloride and 13C6-glucose
were from Cambridge Isotope Laboratories, Inc. (Andover,
MA). Iminodiacetic acid affinity resin was from Sigma. Other
chemicals were reagent grade.
Protein Expression and Purification—Recombinant IpaDwas
prepared by standard methods as previously described (18).
The mxiH5/pET22b was subcloned from pRKmxiHC5 (19,
20). This was the construct used to solve the crystal structure of
MxiHC5 (15). To maintain MxiH in monomeric form, five
codons have been deleted from the 3-end of themxiH coding
sequence,mxiHC5, giving rise toMxiHC5. Thismutation also
prevents polymerization of needles in vivo, resulting in secre-
tion of MxiHC5 monomers but a phenotype that is otherwise
like a mxiH null mutant (19). To obtain uniformly 15N,13C-
labeled MxiHC5, mxiH5/pET22b in E. coli Tuner(DE3) was
grown in minimal medium supplemented with 15N NH4Cl and
13C-glucose as the sole nitrogen and carbon sources, respec-
tively (21). After reachingmid log phase, bacteria were induced
to produce protein with 1 mM isopropyl-1-thio--D-galactopy-
ranoside and grown at 15 °C overnight. Bacteria were collected,
resuspended in IMAC binding buffer (20 mM TrisHCl, pH 7.9,
50 mM NaCl, 5 mM imidazole) and sonicated, and the cellular
debris was removed by centrifugation. Recombinant protein
was purified via His6 tag by IMAC chromatography as
described (20, 22). Fractions were pooled and dialyzed into
appropriate buffers (see below), and the protein concentration
was estimated by UV absorbance at 280 nm.
NMR Spectroscopy—Uniformly 15N- or 15N,13C-labeled
MxiHC5 and unlabeled IpaDwere dissolved inNMRbuffer (10
mM sodiumphosphate, pH 6.0, 10mMNaCl, 10%D2O, and 90%
H2O). NMR data were acquired at 25 °C on a Bruker Avance
800MHz spectrometer fitted with a cryogenic triple-resonance
probe and a Z-axis pulse field gradient. NMR data were pro-
cessed usingNMRPipe (23) and analyzed usingNMRView (24).
Backbone resonances of free MxiHC5 were assigned using
1H-15N HSQC, HNCA, CBCA(CO)NH, and HNCACB
acquired using a 0.8 mM 15N,13C-MxiHC5 sample as described
for BsaLC5 (21). Chemical shift mapping was done by acquir-
ing two-dimensional 1H-15N HSQC at MxiH C5:IpaD molar
ratios of 0.5, 1, 2, 4, and 8. Both IpaD and MxiHC5 were dia-
lyzed into the same buffer prior to titration to assure that the
chemical shift changes were only due to protein-protein inter-
actions and not to changes in solution condition upon mixing.
Preparation of mxiH Mutants for Expression in S. flexneri
SH116—pRKmxiH containing the mxiH gene has been
described (19).mxiHmutants were made by inverse PCR using
pRKmxiH as template, a primer composed of GAGAGA, a
restriction site, and 18 nucleotides flanking the nucleotides to
be deleted and a primer going the opposite direction encoding
GAGAGA, a restriction site, and 18 nucleotides (19). The gen-
eration ofMxiHQ51A has been described (19). The primers used
to introduce mutations into MxiH are given in supplemental
Table S1. The PCR product was digested with the appropriate
restriction enzyme, intramolecularly ligated, and used to trans-
form E. coli NovaBlue. Double-stranded sequencing was per-
formedon eachnewmutantmxiH gene to ensure only the desired
mutationwas incorporated. Each plasmidwas electroporated into
S. flexneri SH116. Ampicillin selection ensured presence of the
plasmid while kanamycin resistance and/or Congo red binding
indicated the presence of the Shigella virulence plasmid.
Phenotypic Characterization of S. flexneri SH116 Expressing
Different mxiHMutants—The phenotype of each newly gener-
ated mxiH point mutant strain of Shigella was determined by
standard assays. Shigella invasion functions were tested using a
gentamycin protection invasion assay with cultured Henle 407
as described (25). Contact-mediated hemolysis with sheep
erythrocytes was used to measure the IpaD-dependent inser-
tion of IpaB and IpaC into target cell membranes as described
(25). The overnight secretion of Ipa proteins into Shigella cul-
ture supernatants was used to ascertain the presence of func-
tional TTSAs and, more specifically, the assembly of functional
MxiH needles with IpaD at the tip as recently described (12).
Induction of type III secretion was tested using Congo red as an
artificial inducer of secretion (19). In S. flexneri, type III secre-
tion occurs upon host cell contact; however, this event can be
mimicked by the addition of Congo red (26). The surface local-
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ization of IpaD was determined using immunofluorescence
microscopy while the ability to polymerize MxiH needles was
determined by transmission electron microscopy as recently
described (12, 19).
Preparation of mxiHC5 Mutants for Expression in E. coli
Tuner(DE3)—To produce monomeric protein, 5 residues were
deleted from the C terminus of MxiH (15). Therefore, the
mutant mxiHC5 genes were copied from the corresponding
pLZ plasmid by PCR using a 5-primer containing GAGAGA,
an NdeI restriction site, and the first 18 bases of mxiH and a
3-primer containingGAGAGA, aXhoI restriction site, and the
last 18 bases of mxiH excluding the stop codon and the last 5
amino acids. The PCR product was digested with NdeI and
XhoI and ligated into correspondingly digested pET22b, and
the ligated product was transformed into E. coli NovaBlue.
Double-stranded sequencing was performed on each new
mutant mxiHC5 gene to confirm that only the desired muta-
tionwas incorporated. The resulting plasmidwas used to trans-
form E. coli Tuner(DE3). This strain was used for purification
of the mutant MxiHC5 proteins as previously described (22).
Fluorescence Polarization—The interaction of IpaD with
MxiHC5 andMxiHC5mutants wasmeasured by fluorescence
polarization (FP) (27). FP provides a measure of the rotational
diffusion for a fluorescent molecule in solution. Small mole-
cules rotate quickly, which produces rapid depolarization of the
population of fluorescent molecules selected using excitation
by polarized light, thus giving rise to lowmillipolarization (mP)
values. In contrast, larger molecules rotate more slowly and
display a reduced rate in depolarization in aqueous solution,
thereby leading to larger mP values. The association of a small
fluorescent species with a larger nonfluorescent species results
in a significant increase in overall molecular volume, thus
resulting in an increase in the mP of the fluorescent species.
IpaD was labeled with fluorescein at its single Cys residue by
combining 1ml of IpaD (3mg/ml) in phosphate-buffered saline
(pH 7.5) with 50l of fluoresceinmaleimide (FM) prepared as a
1 mg/ml stock prepared in N,N-dimethylformamide. After
incubating the mixture for 1 h at 4 °C, the reaction was stopped
by adding dithiothreitol to 1 mM. The FM-IpaD was isolated
from the free fluorophore by gel filtration using SephadexG-50.
FP measurements were obtained using a Beacon fluorescence
polarimeter (Panvera Corp.) as described (27). Briefly, a con-
stant concentration of FM-IpaD (20 nM) in phosphate-buffered
saline was mixed with increasing concentrations of MxiHC5.
The change in FP, measured in millipolarization units (mP),
was monitored after adding nonfluorescent MxiHC5.
RESULTS AND DISCUSSION
MxiHC5 Binding to IpaD—We recently showed that IpaD
localizes to the tip of the TTSA needle (12). Although our find-
ings show that the C-terminal coil of IpaD is responsible for its
maintenance at the MxiH needle tip, no such data are available
to directly demonstrate the structural role of the TTSA needle
protein in the IpaD-MxiH interaction. Using FP to detect in
vitro protein-protein interactions, a direct interaction between
MxiHC5 and IpaD was identified (Fig. 1). IpaD was labeled
with FM at Cys-322, which is the only free thiol in IpaD. Cys-
322 is 10 residues away from the IpaD C terminus, and it is this
portion of IpaD that mediates its stable association with the
ShigellaTTSA needle tip (12). The initial polarization value for
IpaD was 247.9  0.7, a high value that is consistent with the
attachment of the probe to a large (36.6-kDa) protein. FM-IpaD
association with MxiHC5 resulted in a measured increase of
21.2mPwhereas no changewas seen upon the addition of IpgC,
the bacterial cytoplasmic type III secretion system translocator
chaperone (Fig. 1). Because themaximummP achieved by the
addition of anti-IpaD IgG is 30.8, the change in polarization
upon addition of MxiHC5 represents a significant change
based on the fact that itsmass is only one fourth that of IpaD. The
fact that adetectablechange isobservedmost likely stems fromthe
previous observation that IpaD association with theMxiH needle
involves theC terminus of IpaD (12) and this is nearwhere the FM
labeling occurs. The data presented thus indicate that IpaD and
MxiHC5 interactions are detectable in vitro. Furthermore, the
binding data suggest that the twoproteins have an apparent disso-
ciation constant (kd) of 0.48 M (Fig. 1).
Identification of MxiHC5 Residues Interacting with IpaD by
NMR Spectroscopy—We used NMR chemical shift mapping to
identify the MxiHC5 residues that contact IpaD based on the
reasoning that the MxiHC5-IpaD interaction should result in
changes in the NMR resonances of MxiHC5. Because the
smaller MxiHC5 (8.3 kDa) is more amenable to NMR charac-
terization comparedwith IpaD, we titrated unlabeled IpaD into
15N-labeledMxiHC5 and monitored the changes in the chem-
ical shifts of MxiHC5 by acquiring several 15N HSQC spectra
with increasing amounts of IpaD. Indeed, there are NMR peaks
of MxiHC5 that shift upon adding IpaD (Fig. 2). We assigned
the resonances of free MxiHC5 using standard three-dimen-
sional NMR experiments (supplemental Fig. S1). Assigning the
NMR peaks of free MxiHC5 was challenging because of the
broad peaks between 7.8–8.5 ppm in the center of the two-
dimensional 15N HSQC spectra (Fig. 2A). The narrow proton
chemical shift range is consistent with the predominantly
-helical structure of MxiHC5 (15), and the disordered N-ter-
minal 19 residues in the x-ray structure of MxiHC5 (15) likely
contribute to the broad peaks between 7.8–8.5 ppm.Neverthe-
less, using three-dimensional HNCA, CBCA(CO)NH, and
FIGURE 1. Interaction of IpaD with MxiH. FM-labeled IpaD (200 nM) was
incubated with MxiHC5 (F) or IpgC (E). The change in the polarization value
(mP) of the FM-IpaD was measured as a function of MxiH concentration.
Addition of anti-IpaD IgG resulted in a maximum mP of 30.8 (n  3).
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FIGURE 2. A, titration of 15N- MxiHC5 with increasing amounts of unlabeled IpaD. Overlay of six protein-nitrogen correlation spectra (15N HSQC) at various
MxiHC5:IpaD molar ratios (black, 0; red, 0.5; green, 1.0; blue, 2.0; yellow, 4.0; magenta, 8.0). The actual MxiHC5:IpaD concentrations used are as follows (in M):
black (800:0), red (320:160), green (200:200), blue (110:220), yellow (60:240), and magenta (30:250). Peaks with * could not be assigned because they did not show
cross-peaks on the 13C plane in the three-dimensional data sets (HNCA, CBCACONH, and HNCACB) used in the backbone assignments. The insert shows an
expansion of a crowded region of the 15N HSQC. MxiHC5 contains a single tryptophan, and the side chain Trp-10 N1 resonance (at 15n  129.375 and 1H 
10.076) was not perturbed upon addition of IpaD and therefore is not shown. B, the HSQC peaks of individual residues affected by IpaD binding are shown
separately for clarity. MxiH residues that are perturbed by IpaD are mapped on the surface of the crystal structure of MxiH (Protein Data Bank code 2CA5) (15).
C, the back side view of panel B.
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HNCACB (supplemental Fig. S1), we assigned 62 of 78 back-
bone amides of MxiHC5.
Upon adding IpaD to labeled MxiHC5, many MxiHC5
peaks shifted. Further additions of IpaD changed peak positions
even more, indicating that binding was in fast exchange NMR
time scale. This behavior is consistent with the micromolar
binding affinity obtained by fluorescence polarization. The
peaks of the PSNP loop residues (Asn-40, Ser-42, Asn-43, and
Gln-45) and the head group residues (Leu-26, Leu-30, Leu-32,
Ala-33, Leu-34, Tyr-50, Gln-51, Leu-54, and Tyr-57) clearly
shifted to a different part of the spectrum (Fig. 2). The latter set
of residues form a contiguous surface (Fig. 2, B and C) when
mapped on the x-ray crystal structure of MxiHC5 (15). The
side chains of Leu-30, Leu-34, Tyr-50, Gln-51, Leu-54, and
Tyr-57 form one face of the contiguous surface (Fig. 2B), and
the side chains of Leu-26, Leu-32, and Ala-33 are on the “back-
side” (Fig. 2C). Therefore, we propose that themain site of IpaD
binding on MxiHC5 is the surface formed by residues in the
contiguous surface and the PSNP loop.
In Vivo Analysis of MxiH Mutant Strains—We have also
done NMR chemical shift mapping of theMxiH homolog from
Burkholderia pseudomallei, BsaL, and found that the BsaL res-
idues equivalent to MxiH Leu-30, Leu-54, and Tyr-57 are part
of the needle monomer-monomer surface contact.3 Therefore,
we propose that there are two overlapping sites on MxiH: one
for IpaD binding and another for MxiH binding and that the
Leu-30-Leu-54-Tyr-57 surface (see Fig. 2B) is common for both
IpaD and MxiH binding. Hence, MxiH mutations were
designed to disrupt IpaD binding while maintaining theMxiH-
MxiH association. Not all residues that showed chemical shift
changes upon IpaD addition were mutated. Gln-51 was previ-
ously mutated (see Table 1) and it had no effect on IpaD asso-
ciation with the Shigella surface (12, 19). Mutation of Ser-42
was also shown to have no effect on MxiH function (19). Resi-
dues that are not conserved among needle proteins from differ-
ent pathogens were not mutated since the side chain composi-
tion at these positions does not appear to be critical. This was
the case for Leu-26, Leu-32, Ala-33, andGln-45 (15, 28).Where
NMR assignments were lacking, mutations were not intro-
duced because subsequent interpretation of the data would not
be possible. Most importantly, those residues that appeared to
have a role in the packing of MxiH monomers3 were not
mutated because themutations would disrupt needle assembly.
Therefore, we did not mutate the MxiH residues (Leu-30, Leu-
54, Tyr-57) that appeared to be necessary forMxiH-MxiH con-
tacts. In contrast, Leu-47 showedminor chemical shift changes;
however, it is next to the PSNP loop andTyr-50, and it is invari-
ant among the needle proteins of Shigella, Salmonella, and
Burkholderia. In the MxiH structure (15), the side chain of
Leu-47 (which is on helix 2) is oriented toward the surface of
the two-helix bundle (Fig. 2B). This suggests that Leu-47 is not
needed in maintaining the hydrophobic core that dictates the
overall fold of the MxiH structure and thus may be involved in
IpaD binding. Therefore, Leu-47 was mutated.
Asn-40 andAsn-43 of theMxiHPSNP loop and Leu-34, Leu-
47, and Tyr-50 of the contiguous surface were selected for site-
specific mutations. Mutations were made to give MxiHL34A,
MxiHN40A, MxiHN43A, MxiHN43K, MxiHL47A, MxiHL47D,
MxiHY50F, MxiHY50L, and MxiHQ51A (Table 1). For residues
Asn-43, Leu-47, and Tyr-50, two substitutions per residue were
introduced to explore the importance of side chain composi-
tion in needle tip association. MxiHN43A and MxiHN43K were
designed to test the impact of replacing a polar residue with
either a small nonpolar or a somewhat larger, positively charged
residue. MxiHY50F kept the phenyl ring while MxiHY50L main-
tained a hydrophobic side chain. In contrast, the MxiHL47A
mutation decreased the length of the hydrophobic side chain
while MxiHL47D changed the polarity of the region by adding a
negative charge.
The ability of the MxiH mutants to complement the S. flex-
neri mxiH null strain SH116 was assessed using established
phenotypic assays with the data summarized in Table 2 (12).
First, invasion of Henle 407 cells and contact-mediated hemol-
ysis were used to detect the proper introduction of IpaB/IpaC
translocons into targeted cells, which is dependent upon IpaD
localization to the TTSA needle tip (10, 12–14). Second, over-
night secretion of Ipa proteins provided ameasure of functional
needle formation. Excessive overnight secretion can provide a
measure of the loss of IpaD at the needle tip because ipaD null
mutants and IpaD mutants that fail to localize at the needle tip
are known to be hypersecretive (12, 13, 29). Third, induced
(rapid) secretion of Ipa proteins into culture supernatants upon
adding Congo red is lost in ipaD null mutants and this corre-
lateswith the loss of IpaD, but notMxiH, at the bacterial surface
(12). In contrast, loss of needle polymerization results in no Ipa
3 Wang, Y., Picking, W. D., Picking, W. L., and De Guzman, R. N., manuscript in
preparation.
TABLE 1
MxiH mutants used in this study
Mutant proteina Reason for selectionb Source
MxiHL34A Minor chemical shift, somewhat conserved This work
MxiHN40A Major chemical shift, somewhat conserved This work
MxiHN43A Major chemical shift, conserved This work
MxiHN43K Same as above, introduces bulky charged group This work
MxiHL47A Minor chemical shift, highly conserved This work
MxiHL47D Same as above, introduces charged group This work
MxiHY50F Major chemical shift, highly conserved, preserves phenyl ring This work
MxiHY50L Same as above, eliminates phenyl ring, preserves hydrophobic side chain This work
MxiHQ51A Previously shown to retain function and does not interfere with IpaD localization at needle tip (12,19)
a Mutations were introduced into full-length MxiH for complementation analysis using S. flexneri SH116. AMxiHC5 version with a C-terminal His6 was then made for L47A,
L47D, Y50F, Y50L, andQ51A for generation of recombinant protein in E. coli BL21(DE3). The recombinant protein was used for analyzing interactions with FM-labeled IpaD
by fluorescence polarization.
b Chemical shifts refer to the NMR shifts described in Fig. 2. Conserved is a measure of the sequence conservation seen among MxiH and its needle protein homologues from
Salmonella typhimurium (PrgI) and B. pseudomallei (BsaL).
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secretion or detection of MxiH on the bacterial surface (12, 14,
19). Thus, if aMxiHmutant fails tomaintain IpaD at the needle
tip, there will be no invasion, no contact hemolysis, uncon-
trolled overnight secretion, a loss of Congo red-induced Ipa
protein secretion, and no IpaDdetected on the bacterial surface
(12). Because theMxiHmutants were designed not to interfere
withMxiH polymerization, however, MxiH will be detected on
the Shigella surface and it should be possible to overexpress
mxiH to form long versions of the TTSA needle that can be
sheared from the bacterial surface. The phenotypes of themxiH
mutant strains are presented in Table 2.
Asn-40 and Asn-43, which are part of the PSNP loop, were
mutated because they showed someof the largest chemical shift
perturbations upon addition of IpaD (Fig. 2). Previous results
concluded that the polar residues in the PSNP region can tol-
erate mutation to Ala and still give rise to functional needle tip
complexes (19). Similarly, although contact-mediated hemoly-
sis was reduced, N40A and N43A had minimal effects on the
phenotypes that measure the needle tip complex formation
(Table 2). In contrast, mutation of Asn-43 into the somewhat
larger and basic residue Lys decreased needle tip complex for-
mation (Table 2). The decreased ability for this strain to stably
maintain IpaD at the needle tip (50% reduction) resulted in lack
of secretion control as well as inability to invadeHenle 407 cells
and lyse erythrocytes (Table 2). Thus, the PSNP loop interacts
directlywith IpaD and is therefore required for the formation of
the MxiH-IpaD tip complex.
Adjacent to the PSNP loop, Leu-34, Leu-47, Tyr-50, and
Gln-51 form a contiguous surface on the two-helix bundle and
were perturbed upon adding IpaD (Fig. 2B). Although the
chemical shift of Leu-34 was small, it lies within the contiguous
surface, suggesting that Leu-34 could be involved in IpaD bind-
ing. Indeed, the L34A mutation partially reduced invasion and
hemolysis, suggesting that it has aminor effect on IpaD binding
to the needle. Q51A has been characterized (19) and found to
have only a partial defect in secretion control, indicating a
minor deficiency in IpaD affinity for MxiH.
In contrast to Leu-34 and Gln-51, mutation of Leu-47 and
Tyr-50 had significant consequences with regard to S. flexneri
phenotype and the observed interactionswith IpaD in vitro. It is
also noteworthy that Leu-47 and Tyr-50 are highly conserved
among the needle proteins from different species. Both L47A
and L47Dmutants abolished IpaD surface presentation, result-
ing in a noninvasive, nonhemolytic strain that also completely
lacks secretion control (Table 2). These mutations, however,
did not affectMxiH-MxiH interactions since they were capable
of needle formation as detected by immunofluorescence
microscopy (Table 2) aswell as electronmicroscopy (see Fig. 3A
for L47D). When recombinant MxiHC5 proteins possessing
mutations at Leu-47 were prepared so that their interaction
with FM-labeled IpaD could be monitored in vitro using FP, a
measurable decrease in binding to IpaDwas observed (Table 3).
Thus, Leu-47 is critical for IpaD-MxiH binding and the proper
assembly of IpaD at the needle tip.
Tyr-50 is next to Leu-47 on helix 2 of MxiH and its phenyl
ring forms a network of hydrophobic contacts with residues on
helix 1 that contribute to the stability of the two-helix bundle
(15). The hydroxyl group of Tyr-50, however, is pointed toward
the MxiH surface and is not involved in any intramolecular
contacts (15). Therefore, the Tyr-50 hydroxyl group is not
FIGURE 3. Transmission electron micrographs of sheared needles from S.
flexneri SH116 expressing MxiHL47D (A) or MxiHY50F (B) from a pRK2 plas-
mid. Needles were sheared from bacteria in log phase by passage through a
25-gauge needle. The needles were applied to carbon-coated Formvar grids
and negatively stained with 2% uranyl acetate.
TABLE 2
Phenotype of MxiH mutants
Mutant straina Exposed IpaD/MxiHb Invasionc Hemolysisd Uninduced/induced secretione
Wild type / 100  7f 100  14g /
mxiH null / 1  1 2  1 /
MxiHC5 / 0  0 0  0 /
ipaD null / 0  0 0  0 /
MxiHL34A / 44  10 22  5 /
MxiHN40A / 82  5 17  3 /
MxiHN43A / 77  7 25  3 /
MxiHN43K 50%/ 8  3 2  2 /
MxiHL47A / 1  1 2  1 /
MxiHL47D / 1  1 1  0 /
MxiHY50F 20%/ 57  8 9  2 /
MxiHY50L 50%/ 51  6 12  2 /
hMxiHQ51A / 97  8 106  5 /
a Wild type is pRKMxiH/SH116, themxiH null mutant strain is SH116, and the ipaD null mutant is SF622. All other strains are SH116 transformed with the plasmid encoding
one of the MxiH point mutants as described here.
b Surface localization of IpaD andMxiH was determined by immunofluorescence microscopy. At least 100 bacteria in each of three randomly selected fields were counted (n 
3). In most cases, surface localization was either seen on all bacteria or none in a given field. For some mutants, reduced overall fluorescence was visualized and a reduced
number of bacteria were seen with IpaD on their surfaces. In these cases, an approximate percentage of cells having surface IpaD is given.
c Invasion is relative to pRKMxiH/SH116  S.D. (n  3).
d Contact-mediated hemolysis is relative to pRKMxiH/SH116  S.D. (n  3).
e Uninduced secretion is the secretion of TTSS proteins (IpaB and IpaC) into the culture medium during overnight growth. Induced secretion is the secretion of TTSS proteins
by bacteria after a 30-min incubation with Congo red (12,19).
f Raw value of invasion of Henle cells by pRKMxiH/SH116 is 237  15 colonies.
g Raw value of contact-mediated hemolysis of pRKMxiH/SH116 is 2.8  0.02 (A545).
h Values are from Ref. 19.
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required in stabilizing the overall fold of the two-helix bundle.
Structurally, a phenylalanine or leucine in this position would
be expected to maintain the hydrophobic core and the overall
fold of the two-helix bundle, yet Tyr-50 is invariant among the
needle proteins of Shigella, Salmonella, and Burkholderia.
Thus, the mutations Y50F and Y50L were made and the phe-
notypes of each mutant strain determined (Table 2). Although
not as severe as the Leu-47 mutations, Y50L and Y50F resulted
in a 50–80% reduction in IpaD surface presentation, which
negatively affects invasion, hemolysis, or secretion control
(Table 2). Our data, however, show that both Y50F and Y50L
form stable needles in vivo when examined by either immuno-
fluorescence (Table 2) or electron microscopy (Fig. 3). As with
Leu-47, the recombinant MxiHC5 proteins possessing the
Tyr-50mutations were purified to examine their binding inter-
action with FM-labeled IpaD. Indeed, like the Leu-47 mutants,
the Tyr-50 mutants have a notable increase in the apparent
dissociation constant, with Y50F being 3-fold higher and Y50L
being 5-fold higher (Table 3). Thus, although the hydroxyl
group has a role in the stable maintenance of IpaD at the TTSA
needle tip, the hydrophobic interactions through the phenyl
ring appear to contribute more to the in vitro interaction
between IpaD and MxiHC5. Taken together, the data indicate
that key residues of the contiguous face and those of the PNSP
loop contribute to the proper binding, maintenance, and func-
tion of the MxiH-IpaD tip complex (Fig. 4).
Previously, we have shown that the C-terminal coil of IpaD is
required for its association with the MxiH needle and that the
N-terminal globular domain is external to the needle (12).
Modeling using the recently solved individual crystal structures
of MxiH and IpaD, however, was unable to explain how IpaD
docks atop the MxiH needle other than that the orientation is
likely to be the same as that predicted for LcrV (15, 16, 30).
Based on their crystal structures, Johnson et al. (16) proposed a
model for the interaction of MxiH with IpaD based on the fact
that the IpaD N-terminal domain is structurally similar to
MxiH and therefore could serve as a cytoplasmic intramolecu-
lar chaperone that prevents the interaction of IpaD with MxiH
prior to recruitment of the IpaD to the bacterial surface. The
IpaDN-terminal helicesH1 andH2 pack together in such away
that the MxiH structure can be superimposed on the MxiH
two-helix bundle (1 and 2) with a C root mean square devi-
ation of 3.2 Å (Fig. 4, left). This structural similarity is quite
striking considering that the C root mean square deviation
between the two needle homologs BsaL andMxiH is also 3.2 Å
(28). This suggests that IpaD has a built-in surface that comple-
ments the size and shape of that
portion of MxiH that is responsible
for maintaining IpaD at the TTSA
needle tip. Our NMR chemical
shift-mapping results provide the
first biological data to support such
a model in that the MxiH residues
that are perturbed upon adding
IpaD appear to form a contiguous
face (Fig. 4, right) thatmay actually be
contacting a yet unidentified sur-
face on IpaD and this interaction is
blocked in the bacterial cytoplasm
by the presence of the IpaDN termi-
nus. MxiH residues within the
region capable of interacting with
IpaD would include the side chains
of Leu-47 and Tyr-50, which upon
mutation in this study abolished or
severely perturbed IpaD localiza-
tion. Furthermore, in this model,
theMxiH PSNP loop would directly
abut helices H3 and H7 of IpaD and
such an interaction would be steri-
cally impossible based upon the
crystal structure of full-length IpaD
unless the N-terminal domain were
moved away upon tip complex
assembly. Indeed, the chemical
FIGURE 4. Model of MxiH-IpaD binding. Left, the two-helix bundle of MxiH (green, 1 and 2) can be super-
imposed with helices H1 and H2 of IpaD (gray) with a C root mean square deviation of 3.2 Å. Right, the
MxiH-IpaD binding interface is expanded, and the figure is rotated by 180° relative to the orientation in panel
A. The side chains of MxiH residues (Leu-30, Leu-34, Tyr-50, Leu-54, Tyr-57) that showed NMR chemical shift
perturbation upon titration of IpaD as well as Leu-47 are all oriented toward helices H3 and H7 of IpaD. The loop
residues (Asn-40, Ser-42, and Asn-43, red) also showed chemical shift perturbations.
TABLE 3
Association of MxiH mutant proteins with FM-IpaD by fluorescence
polarization
ND, not determined.




Wild type 24.6  2.0 0.48
MxiHL47A 7.8  0.7 2.47
MxiHL47D 1.7  0.9 ND
MxiHY50F 7.6  0.4 1.30
MxiHY50L 12.8  0.8 2.48
MxiHQ51A 24.7  0.9 0.65
a The change in polarization is presented in millipolarization units.
b The apparent dissociation constant was determined using 25 nM FM-IpaD using
Sigmaplot.
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shifts of Asn-40, Ser-42, and Asn-43 demonstrate an interac-
tion between the PSNP loop and IpaD does exist, suggesting
that it is possible that the N-terminal domain moves away
upon tip complex assembly. Unfortunately, at this time we are
unable to predict how the N terminus (helix H1-H2) “swings
away” during tip complex assembly to permit docking atop the
MxiH needle. Because it has been postulated that the needle
channel cannot accommodate a fully folded IpaD (15, 31), it is
possible that it travels through the needle channel in a partially
unfolded manner (31, 32) and that refolding at the needle tip
forces it to assume a conformation that is compatible with the
MxiH-IpaD interactions demonstrated here.
High resolution structures are also available for the MxiH/
IpaD counterparts inB. pseudomallei, BsaL/BipD, and a similar
BsaL-BipD binding model can be generated in which the two-
helix bundle of BsaL can be superimposed to the N-terminal
helices of BipD, alsowith aC rootmean square deviation of 3.2
Å (data not shown). We have also completed the NMR struc-
ture of PrgI (28) and shown that it is structurally homologous to
MxiH and BsaL. The homology of SipD with BipD and IpaD
suggests similarities in the structure of SipD. This suggests that
the model of MxiH-IpaD or BsaL-BipD interaction might be a
common feature of needle tip interaction for Shigella, Salmo-
nella, and Burkholderia.
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The primers used to make the plasmid constructs encoding the mutant proteins are described 













pLZL47A  MxiHL47A 
5’ GAGAGAGAGCAATTGGCTGCTGAATACCAAAGTAAATTA 
5’ GAGAGAGAGCAATTGTGGATTCGAAGGATTTT 
pLZL47D  MxiHL47D  
5’ GAGAGAGAGCAATTGGATGCTGAATACCAAAGTAAATTA 
5’ GAGAGAGAGCAATTGTGGATTCGAAGGATTTT 
pLZY50F MxiHY50F   
5’ GAGAGAGAGCAATTGCTGGCTGAATTTCAAAGTAAATTATCTGAATAT 
5’ GAGAGAGAGCAATTGTGGATTCGAAGGATTTT 
pLZY50L  MxiHY50L 






Supplemental Figure 1. Portion of the 3D HNCA spectra of 15N,13C-MxiH CΔ5, shown as 13C,1H 
strips (the 15N chemical shift is on the Z-axis), for residues W10-L15.  Each strip shows the Cα of 
the current residue and the Cα of the preceding residue, in an HNCA walk or connectivity.  The 
HNCA data, together with CBCA(CO)NH and HNCACB data, confirms the backbone 
assignments for W10-L15.  The backbone assignments for the rest of the protein were obtained in 
a similar manner.  HNCA spectra were acquired using a 0.8 mM 15N,13C-MxiH CΔ5 sample at 800 
MHz and 25°C.  
 
 
Supplementary Figure 2. Portion of the 3D CBCA(CO)NH spectra of 15N,13C-MxiHCΔ5 shown as 
13C,1H strips for W10 to L15 (the 15N ppm is on the Z-axis).  The CBCA(CO)NH experiment 
shows unambiguously the Cα and Cβ of the preceeding residue together with backbone amide (1H 
and 15N) of the current  residue. The CBCA(CO)NH data is used together with HNCA and 
HNCACB to assign the backbone resonances of free MxiHCΔ5. The spectra were acquired using a 
0.8 mM 15N,13C-MxiH CΔ5 sample at 800 MHz and 25°C. 
 
 
Supplementary Figure 3. Portion of the 3D HNCACB spectra of 15N,13C-MxiHCΔ5, shown as 
13C,1H strips for T11-S16 (the 15N ppm is on the Z-axis).   Each strip shows the Cα and Cβ of the 
preceeding and current residue and the amide (1H and 15N) resonances of the current residue.  The 
Cα and Cβ have opposite phases (shown as black and red peaks).  In theory, the 3D HNCACB 
dataset contains all the information needed in assigning all the backbone resonances of a protein. 
However, this experiment is insensitive, and was used in combination with the more sensitive 
HNCA and CBCA(CO)NH experiments to complete the backbone assignments of free MxiHCΔ5. 
The spectra were acquired using a 0.8 mM 15N,13C-MxiH CΔ5 sample at 800 MHz and 25°C. 
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